These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29220341)

  • 1. Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland.
    Suvikas-Peltonen E; Palmgren J; Häggman V; Celikkayalar E; Manninen R; Airaksinen M
    Int J Pharm Compd; 2017; 21(6):518-529. PubMed ID: 29220341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and content validation of an assessment tool for medicine compounding on hospital wards.
    Suvikas-Peltonen E; Granfors E; Celikkayalar E; Laaksonen R; Palmgren J; Airaksinen M
    Int J Clin Pharm; 2016 Dec; 38(6):1457-1463. PubMed ID: 27817169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recommendations for the safety preparation of sterile medicines in medical wards].
    Martín de Rosales Cabrera AM; López Cabezas C; Pernía López MS; Dávila Pousa C; Vila Clérigues MN; Alonso Herreros JM; García Salom P; Lozano Blázquez A
    Farm Hosp; 2014 Jan; 38(1):57-64. PubMed ID: 24483861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapting and remodelling the US Institute for Safe Medication Practices' Medication Safety Self-Assessment tool for hospitals to be used to support national medication safety initiatives in Finland.
    Celikkayalar E; Myllyntausta M; Grissinger M; Airaksinen M
    Int J Pharm Pract; 2016 Aug; 24(4):262-70. PubMed ID: 26811257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Council of Europe Resolution CM/Res(2016)2: a major contribution to patient safety from reconstituted injectable medicines?
    Beaney AM; Le Brun P; Ravera S; Scheepers H
    Eur J Hosp Pharm; 2020 Jul; 27(4):216-221. PubMed ID: 32587080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Chemotherapy Compounding Errors in a Follow-Up Pan-Canadian Observational Study.
    Gilbert RE; Kozak MC; Dobish RB; Bourrier VC; Koke PM; Kukreti V; Logan HA; Easty AC; Trbovich PL
    J Oncol Pract; 2018 May; 14(5):e295-e303. PubMed ID: 29676947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment.
    Sabatini L; Paolucci D; Marinelli F; Pianetti A; Sbaffo M; Bufarini C; Sisti M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e63-e68. PubMed ID: 32296508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies implementation to reduce medicine preparation error rate in neonatal intensive care units.
    Campino A; Santesteban E; Pascual P; Sordo B; Arranz C; Unceta M; Lopez-de-Heredia I
    Eur J Pediatr; 2016 Jun; 175(6):755-65. PubMed ID: 26670025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs.
    Geersing TH; Franssen EJF; Pilesi F; Crul M
    Eur J Pharm Sci; 2019 Mar; 130():181-185. PubMed ID: 30710619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide.
    Sugiura S; Asano M; Kinoshita K; Tanimura M; Nabeshima T
    J Oncol Pharm Pract; 2011 Mar; 17(1):14-9. PubMed ID: 20179165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved aseptic technique can reduce variable contamination rates of ward-prepared parenteral doses.
    Austin P; Elia M
    J Hosp Infect; 2013 Feb; 83(2):160-3. PubMed ID: 23313030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A first-phase quality assurance program for intravenous admixture aseptic technique.
    Gurwich EL; Hanold L; Schaeffer P
    Hosp Pharm; 1982 Mar; 17(3):119-21. PubMed ID: 10255637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices.
    Brzozowski DF; Hale KM; Segal R; Mirtallo JM
    Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auditing sterile compounding competency with video observation.
    Connor TK; Lim JH; Hinton TM
    Am J Health Syst Pharm; 2017 Aug; 74(16):1218-1219. PubMed ID: 28790073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.